View Clinical Trial (Medical Research Study)
Alzheimer's Disease - Miami FL (Clinical Trial 5749) (Clinical Trial 5749)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials. 
|
 |
 |
| City: |
|
Miami |
| State: |
|
FL |
| Zip Code: |
|
33126 |
| Study summary: |
|
For this study you must attend 15 study visits during an 83-week period. You would receive six infusions of the investigational drug every 13 weeks for 65 weeks. You would have blood tests and study-related physical and clinical exams. Participants will be randomly assigned to receive one of three doses of the investigational drug or placebo (a treatment with no active ingredient). There is a 60-percent chance of receiving the investigational drug and a 40-percent chance of receiving a placebo.
Alzheimer’s disease is a neurodegenerative disorder—a disorder in which brain cells are lost. It is characterized by progressive loss of memory and cognitive function, such as movement control and decision-making ability. |
| Qualified participants must: |
|
• Be 50 to 88 years of age
•
Have a diagnosis of probable Alzheimer’s disease
•
Have a caregiver who is willing to be involved in the study with you |
| Participants will receive: |
|
Participants will receive, at no charge, the investigational drug, physical exams, and laboratory services and tests. Throughout the study, participants will be monitored by a
medical team including a nurse or study coordinator and a physician.
|
|
|
|
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
|
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.